Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

Kenchaiah, S; Pocock, SJ; Wang, D; Finn, PV; Zornoff, LA; Skali, H; Pfeffer, MA; Yusuf, S; Swedberg, K; Michelson, EL; +4 more... Granger, CB; McMurray, JJ; Solomon, SD; CHARM Investigators; (2007) Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation, 116 (6). pp. 627-36. ISSN 0009-7322 DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.679779

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1161/CIRCULATIONAHA.106.679779

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar